Future Cardia key facts
as of Oct 2026- Developer of a digital health insertable cardiac device designed to monitor atrial fibrillation and heart failure progression and reduce unnecessary hospitalization.
- Future Cardia is valued at approximately $53.1M as of Oct 2026 (last reported valuation).
- It has raised $16.5M; the latest was Equity Crowdfunding ($2.1M) in Dec 2024.
- Notable investors include StartX (US), Texas Medical Center, Tampa Bay Wave, Zain S Hasan Charitable Remainder Trust, Aria Emiko (Investment) — 28 tracked in total.
- Status: Privately Held (backing).
Future Cardia's last reported valuation, Dec 2024. Nothing priced has surfaced since.
- ·The complete investor list: 28 names
- ·Watch Future Cardia: the Monday email on marks, rounds and moves
Future Cardia funding rounds
No funding rounds for Future Cardia are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Future Cardia
28+Future Cardia valuation
Future Cardia's last reported valuation was $53.1 million in Dec 2024. No priced round, secondary trade or fund mark has surfaced since.
Future Cardia investors
28 investors are on record for Future Cardia, including StartX (US), Texas Medical Center, Tampa Bay Wave and Zain S Hasan Charitable Remainder Trust. By type, the record holds 4 venture capital firms and 1 family office.
About Future Cardia
Developer of a digital health insertable cardiac device designed to monitor atrial fibrillation and heart failure progression and reduce unnecessary hospitalization. The company provides a monitoring tool that is covered with a special band-aid and goes under the skin, helping people to transmit encrypted cardiac data to a smartphone.
- Sector
- Healthcare
- HQ
- Houston, TX, United States
- Founded
- 2019
- Employees
- 13
- Website
- futurecardia.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.